The patient had left lung cancer with left supraclavicular lymph node metastasis, staged as cT2aN3M0. They received one course of chemotherapy with "Bevacizumab + Pemetrexed + Carboplatin" at a local provincial-level cancer hospital and one month of oral Gefitinib targeted therapy. Follow-up chest CT revealed an increase in the size of the lung lesion (approximately 3.4cm × 2.8cm). They were subsequently referred to our hospital, where they underwent one course of arterial infusion chemotherapy + embolization. During the procedure, 16 iodine-125 particles were implanted. They also began taking Osimertinib as targeted therapy. After 25 days, a follow-up examination showed a significant reduction in the tumor tissue.
BEFORE
AFTER

Regular patient satisfaction surveys reveal that most patients highly commend our efficient and accurate diagnostic services, noting the demeanor of our staff, which eased their anxiety and boosted confidence in subsequent treatments.